Drug Profile
Research programme: oxycodone abuse-resistant - Acura Pharmaceuticals
Alternative Names: LTX-01; Oxycodone abuse-resistant - Acura PharmaceuticalsLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Acura Pharmaceuticals
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for research development in Pain in USA (PO)
- 07 Sep 2016 Early research in Pain in USA (PO)